Related Experiment Videos
Thyrotoxic atrial fibrillation: an underdiagnosed or overdiagnosed condition?
B Fagerberg1, G Lindstedt, S O Strömblad
1Department of Medicine I, Sahlgren's Hospital, Gothenburg University, Sweden.
Clinical Chemistry
|April 1, 1990
Summary
Hyperthyroidism is often underdiagnosed in atrial fibrillation patients. Standard thyroliberin stimulation tests may require revised criteria for accurate diagnosis of thyroid dysfunction in these cases.
Area of Science:
- Endocrinology
- Cardiology
- Internal Medicine
Background:
- Hyperthyroidism is a potential, yet often overlooked, cause of atrial fibrillation.
- Thyroid function assessment is crucial in patients presenting with cardiac arrhythmias.
Purpose of the Study:
- To clinically and biochemically assess thyroid function in ambulatory atrial fibrillation patients.
- To evaluate the diagnostic utility of the thyroliberin stimulation test in this population.
Main Methods:
- Clinical and biochemical assessment of thyroid function in 110 ambulatory atrial fibrillation patients.
- Thyroliberin stimulation testing performed on all participants.
- Follow-up assessment of patients with equivocal test results.
Main Results:
- Only 2.7% of patients met hyperthyroidism criteria, with only one identified clinically.
- Thyroliberin stimulation tests identified seven additional patients with potentially abnormal responses.
- These seven patients were not ultimately classified as hyperthyroid after follow-up and thyroid hormone analysis.
Conclusions:
- Current criteria for interpreting thyroliberin stimulation tests in atrial fibrillation patients may need revision.
- The thyroliberin stimulation test remains valuable when thyrotropin determination is equivocal.
- Improved diagnostic methods are needed to clarify hyperthyroidism's role in atrial fibrillation pathogenesis.